Carlos Esparza, MD
Physical Medicine & Rehabilitation · Albuquerque, NMNPI 1255399630
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 72 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Nevro Corp. accounts for 62.1% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $343 and has fallen 50.0% since, to $171 in 2025.
Across 72 payments — averaging $17.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$780
- Globus Medical$137
- Scilex Pharmaceuticals Inc.$132
- Electronic Waveform Lab, Inc.$108
- Abbott$46
- Medtronic$34
- plus $19 from 1 others
What the payments were for
- Travel & lodging$192%
- Food & beverage$1,23798%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 43 | $780 |
| Globus Medical | 6 | $137 |
| Scilex Pharmaceuticals Inc. | 8 | $132 |
| Electronic Waveform Lab, Inc. | 11 | $108 |
| Abbott | 2 | $46 |
| Medtronic | 1 | $34 |
| Intuitive Surgical | 1 | $19 |
How this compares
$1,256 in reported general payments places this provider in the 75th percentile of 41 physical medicine & rehabilitation providers in New Mexico.
See all physical medicine & rehabilitation providers in New Mexico →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hysingla ErHydrocodone Bitartrate | 11 | $3,731 |
| Oxycodone Hcl | 135 | $3,617 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 121 | $3,045 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 68 | $2,776 |
| Gabapentin | 89 | $1,415 |
| Tizanidine Hcl | 51 | $768 |
| Morphine Sulfate ErMorphine Sulfate | 20 | $327 |
| Cyclobenzaprine Hcl | 16 | $240 |
| Pregabalin | 17 | $194 |
| Celecoxib | 18 | $170 |
| Tramadol Hcl | 30 | $166 |
| Methylprednisolone | 15 | $136 |
| Ibuprofen | 11 | $133 |
| Diazepam | 19 | $55 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Albuquerque
- Reza EhsanianAlbuquerque$19K
- Christopher BurtonAlbuquerque$10K
- Martin ManansalaAlbuquerque$7K
- Terry HansenAlbuquerque$7K
- John SloanAlbuquerque$6K
- Jack ChienAlbuquerque$5K
- Julie MucheAlbuquerque$3K
- Gwen LacerdaAlbuquerque$2K
- Pamela BlackAlbuquerque$1K
- Anthony ReeveAlbuquerque$526
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.